BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33792560)

  • 1. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.
    Liikanen I; Lauhan C; Quon S; Omilusik K; Phan AT; Bartrolí LB; Ferry A; Goulding J; Chen J; Scott-Browne JP; Yustein JT; Scharping NE; Witherden DA; Goldrath AW
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33792560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Hypoxia-Inducible Factor Expression in CD8
    Veliça P; Cunha PP; Vojnovic N; Foskolou IP; Bargiela D; Gojkovic M; Rundqvist H; Johnson RS
    Cancer Immunol Res; 2021 Apr; 9(4):401-414. PubMed ID: 33602720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
    Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW
    Nat Immunol; 2013 Nov; 14(11):1173-82. PubMed ID: 24076634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection.
    Liu R; Muliadi V; Mou W; Li H; Yuan J; Holmberg J; Chambers BJ; Ullah N; Wurth J; Alzrigat M; Schlisio S; Carow B; Larsson LG; Rottenberg ME
    Nat Commun; 2022 Sep; 13(1):5093. PubMed ID: 36064840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
    Greene CJ; Sharma NJ; Fiorica PN; Forrester E; Smith GJ; Gross KW; Kauffman EC
    Free Radic Biol Med; 2019 Mar; 133():295-309. PubMed ID: 30553971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8
    Li C; Zhu B; Son YM; Wang Z; Jiang L; Xiang M; Ye Z; Beckermann KE; Wu Y; Jenkins JW; Siska PJ; Vincent BG; Prakash YS; Peikert T; Edelson BT; Taneja R; Kaplan MH; Rathmell JC; Dong H; Hitosugi T; Sun J
    Immunity; 2019 Sep; 51(3):491-507.e7. PubMed ID: 31533057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
    Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
    J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-resident memory CD8
    Wang T; Shen Y; Luyten S; Yang Y; Jiang X
    Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
    Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
    Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
    Carmona-Rodríguez L; Martínez-Rey D; Fernández-Aceñero MJ; González-Martín A; Paz-Cabezas M; Rodríguez-Rodríguez N; Pérez-Villamil B; Sáez ME; Díaz-Rubio E; Mira E; Mañes S
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia enhances CD8
    Ning F; Takeda K; Schedel M; Domenico J; Joetham A; Gelfand EW
    J Allergy Clin Immunol; 2019 Jun; 143(6):2026-2037.e7. PubMed ID: 30660639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx3 programs CD8
    Milner JJ; Toma C; Yu B; Zhang K; Omilusik K; Phan AT; Wang D; Getzler AJ; Nguyen T; Crotty S; Wang W; Pipkin ME; Goldrath AW
    Nature; 2017 Dec; 552(7684):253-257. PubMed ID: 29211713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.